துணிகர இன்குபேட்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from துணிகர இன்குபேட்டர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In துணிகர இன்குபேட்டர் Today - Breaking & Trending Today

Sequana Medical NV: Transparency Notifications from Shareholders


Sequana Medical NV: Transparency Notifications from Shareholders
Ghent, BELGIUM - 23 February 2021 -
Sequana Medical NV (Euronext Brussels: SEQUA) (the
Company or
Sequana
Medical ), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions (the
Belgian Transparency Act ) that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. ....

United States , Chris Maggos , Dina Chaya , Belgian Companies , Sequana Holding , Neomed Iv Extension Limited , Neomed Management Jersey Limited , Belgian Financial Services , Health Economics Fund Management , Neomed Innovationv Limited , Neomed Iv Extension Limited Innovation , Management Group , Company Or Sequanamedical , Neomed Management Jersey , Euronext Brussels , Belgian Act , Neomed Management , Erik Amble , Claudio Nessi , Associations Code , Venture Incubator , Sequana Medical , Belgian Transparency Act , Markets Authority , Direct Sodium Removal , North American ,

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman


Share this article
Share this article
MADRID, Feb. 10, 2021 /PRNewswire/ MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II. Having achieved pre-clinical feasibility in 2020, these proceeds will now enable MedLumics to initiate first in-human regulatory clinical studie ....

Comunidad Autonoma De Cataluna , Comunidad Autonoma De Aragon , Olivier Litzka , Prnewswire Medlumics , James Greene , Peter Neubeck , Kurma Biofund , University Of South Florida , Medlumics Ireland Ltd , Sabadell Asabys Health Innovation Investments , European Fund For Strategic Investments , Its Life Sciences , Stanford Biodesign Emerging Entrepreneurs Forum , Stanford Coulter Foundation For Translational Medicine , Ashland University , European Union , Life Sciences , Vi Partners Swiss Innovation Fund , Atrial Fibrillation , Erich Ferrari , Asabys Partners , Swiss Innovation , Andera Partners , Caixa Capital Risc , Innogest Capital , Managing Director ,